Genic제닉
123330 · KOSDAQ · ₩123330 · 제닉
₩16,580▲ ₩200 (1.22%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 24.4% | 28.8% | 23.3% | 11.5% | 8.6% | 18.0% |
| Operating margin | 16.8% | 19.1% | 12.1% | −14.3% | −10.1% | −10.3% |
| Net margin | 25.9% | 24.2% | 15.2% | −15.7% | −10.6% | −11.3% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +46.2% | +56.7% | +77.8% | −10.7% | −18.1% | — |
| Operating income growth | +27.9% | +148.6% | +249.7% | −26.8% | +19.5% | — |
| Net income growth | +56.6% | +149.7% | +271.5% | −32.1% | +22.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 61.1% | 59.8% | 44.9% | −32.1% | −19.0% | −22.4% |
| Return on assets | 35.4% | 39.9% | 24.6% | −16.4% | −8.8% | −9.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 63.0% | 37.7% | 72.2% | 102.9% | 90.4% | 135.3% |
| Net debt to equity | −1.2% | −26.9% | 16.7% | 46.2% | 47.3% | 15.2% |
| Current ratio | 182.8% | 237.3% | 136.3% | 80.8% | 108.4% | 188.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Genic / 제닉 / 123330 / KRX:123330
Source: KRX statistical information